XTX Topco’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History

XTX Topco’s Portfolio ASLN Stock Details ASLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,726	Closed	-$4.14K	–	2753
2024 Q2	$4.14K	Buy	1,726 +183	+12%	+$648	﹤0.01%	1756
2024 Q1	$7.59K	Sell	1,543 -1,915	-55%	-$9.6K	﹤0.01%	1690
2023 Q4	$14.4K	Buy	+3,458	New	+$26.1K	﹤0.01%	1395

Other funds holding ASLN

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

XTX Topco's ASLN Position: Q3 2024 in Review

XTX Topco sold out of ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) in Q3 2024, closing a stake of 1,726 shares — an estimated $4.14K sold.

XTX Topco first reported a position in ASLN in Q4 2023 and held it in 3 quarters. The position peaked at $14.4K in Q4 2023. 1 fund tracked by Wall St. Rank holds ASLN as of Q3 2024.

XTX Topco reported no remaining ASLAN Pharmaceuticals Limited American Depositary Shares position as of Q3 2024 after selling out during the quarter.
XTX Topco sold 1,726 ASLAN Pharmaceuticals Limited American Depositary Shares shares in Q3 2024, an estimated $4.14K.
XTX Topco first reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares in Q4 2023 and held it in 3 quarters.
XTX Topco's ASLAN Pharmaceuticals Limited American Depositary Shares position peaked at $14.4K in Q4 2023.
1 fund tracked by Wall St. Rank held ASLAN Pharmaceuticals Limited American Depositary Shares as of Q3 2024.

Based on XTX Topco's 13F filing for Q3 2024, filed 14 Nov 2024.